Bordetella pertussis, Finland and France.
We used pulsed-field gel electrophoresis analysis and genotyping to compare clinical isolates of Bordetella pertussis recovered since the early 1990s in Finland and France, 2 countries with similar histories of long-term mass vaccination with whole-cell pertussis vaccines. Isolates from both countries were similar genetically but varied temporally.
Caro
Valérie
V
Institut Pasteur, Unité PTMMH, FRE-CNRS 2849, National Center of Reference of Whooping Cough and Other Bordetelloses, Paris, France. vcaro@pasteur.fr
Elomaa
Annika
A
Brun
Delphine
D
Mertsola
Jussi
J
He
Qiushui
Q
Guiso
Nicole
N
D001425:Bacterial Outer Membrane Proteins / Q000737:chemistry / Q000235:genetics; D001886:Bordetella pertussis / Q000145:classification* / Q000235:genetics / Q000276:immunology; D004269:DNA, Bacterial / Q000737:chemistry / Q000235:genetics; D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000276:immunology*; D016521:Electrophoresis, Gel, Pulsed-Field; D036781:Fimbriae Proteins / Q000737:chemistry / Q000235:genetics; D005387:Finland / Q000453:epidemiology; D005602:France / Q000453:epidemiology; D014644:Genetic Variation; D006801:Humans; D037342:Pertussis Toxin / Q000737:chemistry / Q000235:genetics; D010566:Virulence Factors, Bordetella / Q000737:chemistry / Q000235:genetics; D014917:Whooping Cough / Q000453:epidemiology / Q000276:immunology / Q000382:microbiology*
D001425:Bacterial Outer Membrane Proteins; D004269:DNA, Bacterial; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D010566:Virulence Factors, Bordetella; C083388:pertussis toxin, S1 subunit; D036781:Fimbriae Proteins; C068929:pertactin; D037342:Pertussis Toxin